Effect of Levothyroxine Suppression Therapy on Plasma Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels in Benign Thyroid Nodules

Publisher： Karger

E-ISSN： 1423-0151|20|1|23-28

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.20, Iss.1, 2010-12, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation

By Watanabe R.   Wada H.   Watanabe Y.   Sakakura M.   Nakasaki T.   Mori Y.   Nishikawa M.   Gabazza E.C.   Nobori T.   Shiku H.  

Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome

By  

Cerebrovascular Diseases, Vol. 42, Iss. 5-6, 2016-07 ,pp. : 404-414

Karger

Access to resources Recommend Favorite

Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients

By  

Medical Principles and Practice, Vol. 20, Iss. 4, 2011-05 ,pp. : 332-335

Karger

Access to resources Recommend Favorite

Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels

By Ozkan Gulsum  

Clinical and Experimental Hypertension, Vol. 35, Iss. 2, 2013-04 ,pp. : 134-140

Informa Healthcare

Access to resources Recommend Favorite

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI, Plasma Procarboxypeptidase B, Procarboxypeptidase R, Procarboxypeptidase U)

By Bouma B.N.   Marx P.F.   Mosnier L.O.   Meijers J.C.M.  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 329-354

Elsevier

Access to resources Recommend Favorite